🇺🇸 FDA
Patent

US 10143219

Nutritional supplement/feed formula and methods of use thereof to reduce development of Osteochondrosis Dissecans (OCD) lesions

granted A61KA61K31/197A61K31/202

Quick answer

US patent 10143219 (Nutritional supplement/feed formula and methods of use thereof to reduce development of Osteochondrosis Dissecans (OCD) lesions) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE TRUSTEES OF PRINCETON UNIVERSITY
Grant date
Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/197, A61K31/202, A61K31/355, A61K31/375